Article
Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Feb 2006
Kubuschok Boris, Neumann Frank, Breit Rainer, Sester Martina, Schormann Claudia, Wagner Claudia, Sester Urban, Hartmann Frank, Wagner Mathias, Remberger Klaus, Schilling Martin, Pfreundschuh Michael
Abstract excerpt
Mutated p21 ras proteins (muRas) are present in approximately 90% of pancreatic adenocarcinomas and express mutants which can function as cancer-specific antigens. To evaluate the frequency and magnitude of the natural T-cell response against muRas in 19 HLA-A2-positive patients with muRas-positive pancreatic carcinomas, antigen-experienced T lymphocytes in fresh peripheral blood mononuclear cells were shown by...
Topics
- Adenocarcinoma
- CD4-Positive T-Lymphocytes
- CD8-Positive T-Lymphocytes
- Cell Line, Tumor
- Cross Reactions
- Cytotoxicity Tests, Immunologic
- Cytotoxicity, Immunologic
- DNA Mutational Analysis
- Enzyme-Linked Immunosorbent Assay
